SWM
RPRX icon

Spire Wealth Management’s Royalty Pharma RPRX Stock Holding History

Spire Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,195
Closed -$37.2K – 2528
2025
Q1 		$37.2K Sell
1,195
-954
-44% -$30.2K ﹤0.01% 1392
2024
Q4 		$54.8K Buy
2,149
+1,699
+378% +$45.1K ﹤0.01% 1248
2024
Q3 		$12.7K Hold
450
– – ﹤0.01% 1574
2024
Q2 		$11.9K Hold
450
– – ﹤0.01% 1597
2024
Q1 		$13.7K Hold
450
– – ﹤0.01% 1621
2023
Q4 		$13.1K Hold
450
– – ﹤0.01% 1671
2023
Q3 		$12.2K Hold
450
– – ﹤0.01% 1666
2023
Q2 		$13.8K Hold
450
– – ﹤0.01% 1717
2023
Q1 		$16.2K Hold
450
– – ﹤0.01% 1692
2022
Q4 		$18K Hold
450
– – ﹤0.01% 1411
2022
Q3 		$18K Buy
+450
New +$19.2K ﹤0.01% 1375

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return